Aerovate Therapeutics
AVTE
#9017
Rank
NZ$0.13 B
Marketcap
$4.56
Share price
1.92%
Change (1 day)
-80.96%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$29.65 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are NZ$29.65 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$13.47 M212.63%
2021-12-31NZ$4.31 M-82.77%
2020-12-31NZ$25.02 M135.52%
2019-12-31NZ$10.62 M